Introduction: Bruck syndrome is a rare autosomal recessive disease characterized by multiple joint contractures, bone fragility, and fractures. Two genes have been associated with Bruck syndrome, FKBP10 and PLOD2, though they are phenotypically indistinguishable. Case Presentation: We present a prenatally diagnosed case of Bruck syndrome in a young multiparous woman, with no notable personal, family or obstetric history. A 12-week ultrasound raised the suspicion of short long bones, subsequently confirmed at 16 weeks. In addition, bilateral fixed flexion of the elbow, wrist, and knee joints as well as talipes was observed. Chromosomal SNP microarray analysis (0.2 Mb) detected a homozygous deletion at chromosome 3, band q24, involving a part of PLOD2 to a part of PLSCR4. At mid-trimester morphology, bilateral intrauterine fractures of the humerus and femur were evident. In the late third trimester, a fetal echocardiogram noted enlargement of the right heart with severe tricuspid regurgitation in combination with pulmonary insufficiency and a restrictive arterial duct. The potential risk of premature closure of the ductus arteriosus near term led to delivery by emergency caesarean section. Conclusion: To our knowledge, this is the first case of Bruck syndrome prenatally confirmed by chromosomal microarray analysis and the second reported case with an extra-skeletal abnormality. This case highlights the importance of comprehensive fetal morphological assessment during pregnancy as diagnosis of an additional abnormality has the potential to impact both management and prognosis.

Keywords:
Bruck syndrome, Congenital heart disease, Skeletal dysplasia, PLOD2, Prenatal fractures
1.
Santana A, Oleas-Santillán G, Franzone JM, Nichols LR, Bowen JR, Kruse RW. Orthopedic manifestations of Bruck syndrome: a case series with intermediate to long-term follow-up. Case Rep Orthop. 2019;2019:8014038.
2.
Bank RA, Robins SP, Wijmenga C, Breslau-Siderius LJ, Bardoel AFJ, Van der Sluijs HA, et al. Defective collagen crosslinking in bone, but not in ligament or cartilage, in Bruck syndrome: indications for a bone-specific telopeptide lysyl hydroxylase on chromosome 17. Proc Natl Acad Sci U S A. 1999;96(3):1054–8.
3.
Bruck A. Ueber eine seltene Form von Erkrankung der Knochen und Gelenke1. Dtsch Med Wochenschr. 1897 Mar;23(10):152–5.
4.
Viljoen D, Versfeld G, Beighton P. Osteogenesis imperfecta with congenital joint contractures (Bruck syndrome). Clin Genet. 1989 Aug;36(2):122–6.
5.
Afşarlar ÇE, Peltek-Kendirci HN, Erdoğan D, Özgüner İF, Çavuşoğlu YH, Karaman A, et al. The first case of Bruck syndrome associated with gastroschisis. Turk J Pediatr. 2013;55(6):651–4.
6.
Berg C, Geipel A, Noack F, Smrcek J, Krapp M, Germer U, et al. Prenatal diagnosis of Bruck syndrome. Prenat Diagn. 2005 Jul;25(7):535–8.
7.
Cuillier F, Alessandri JL, Lemaire P, Fritel X, Harper L. Bruck syndrome: second antenatal diagnosis. Fetal Diagn Ther. 2007;22(1):23–8.
8.
Zhang J, Hu H, Mu W, Yu M, Chen W, Mi D, et al. Case report: exome sequencing identified a novel compound heterozygous variation in PLOD2 causing Bruck syndrome type 2. Front Genet. 2021 Feb 16;12:619948.
9.
Fotiadou AN, Calleja M, Hargunani R, Keen R. Skeletal manifestations of osteogenesis imperfecta. Seminars Musculoskelet Radiol. 2016;20(3):279–86.
10.
Basel D, Steiner RD. Osteogenesis imperfecta: recent findings shed new light on this once well-understood condition. Genet Med. 2009 Jun 1;11(6):375–85.
11.
Yüksel Ülker A, Uludağ Alkaya D, Elkanova L, Şeker A, Akpınar E, Akarsu NA, et al. Long-term follow-up outcomes of 19 patients with osteogenesis imperfecta type XI and Bruck syndrome type I caused by FKBP10 variants. Calcif Tissue Int. 2021 Dec;109(6):633–44.
12.
Shaheen R, Al-Owain M, Faqeih E, Al-Hashmi N, Awaji A, Al-Zayed Z, et al. Mutations in FKBP10 cause both Bruck syndrome and isolated osteogenesis imperfecta in humans. Am J Med Genet A. 2011 Jun;155A(6):1448–52.
13.
Mokete L, Robertson A, Viljoen D, Beighton P. Bruck syndrome: congenital joint contractures with bone fragility. J Orthop Sci. 2005 Nov;10(6):641–6.
14.
Lv F, Xu X, Song Y, Li L, Wang J, Wang J, et al. Novel mutations in PLOD2 cause rare Bruck syndrome. Calcif Tissue Int. 2018 Mar;102(3):296–309.
15.
Brenner RE, Vetter U, Stöss H, Müller PK, Teller WM. Defective collagen fibril formation and mineralization in osteogenesis imperfecta with congenital joint contractures (Bruck syndrome). Eur J Pediatr. 1993 Jun;152(6):505–8.
16.
Cho TJ, Ko JM, Kim H, Shin HI, Yoo WJ, Shin CH. Management of osteogenesis imperfecta: a multidisciplinary comprehensive approach. Clin Orthop Surg. 2020 Dec;12(4):417–29.
17.
Gistelinck C, Witten PE, Huysseune A, Symoens S, Malfait F, Larionova D, et al. Loss of type I collagen telopeptide lysyl hydroxylation causes musculoskeletal abnormalities in a zebrafish model of Bruck syndrome. J Bone Miner Res. 2016 Nov;31(11):1930–42.
18.
Pauschinger M, Doerner A, Remppis A, Tannhäuser R, Kühl U, Schultheiss HP. Differential myocardial abundance of collagen type I and type III mRNA in dilated cardiomyopathy: effects of myocardial inflammation. Cardiovasc Res. 1998;37(1):123–9.
19.
Folkestad L, Hald JD, Gram J, Langdahl BL, Hermann AP, Diederichsen AC, et al. Cardiovascular disease in patients with osteogenesis imperfecta: a nationwide, register-based cohort study. Int J Cardiol. 2016 Dec 15;225:250–7.
20.
Brower GL, Gardner JD, Forman MF, Murray DB, Voloshenyuk T, Levick SP, et al. The relationship between myocardial extracellular matrix remodeling and ventricular function. Eur J Cardiothorac Surg. 2006;30(4):604–10.
21.
Ashournia H, Johansen FT, Folkestad L, Diederichsen AC, Brixen K. Heart disease in patients with osteogenesis imperfecta: a systematic review. Int J Cardiol. 2015 Oct 1;196:149–57.
22.
Gistelinck C, Weis M, Rai J, Schwarze U, Niyazov D, Song KM, et al. Abnormal bone collagen cross-linking in osteogenesis imperfecta/bruck syndrome caused by compound heterozygous PLOD2 mutations. JBMR Plus. 2021 Mar;5(3):e10454.
23.
Subramanian S, Viswanathan VK. Osteogenesis imperfecta. In: StatPearls [internet]. Treasure Island (FL): StatPearls Publishing; 2022.
24.
Bamshad M, Van Heest AE, Pleasure D. Arthrogryposis: a review and update. J Bone Jt Surg. 2009;91(Suppl 4):40–6.
25.
Woodward PJ. Diagnostic imaging: obstetrics E-book: Elsevier Health Sciences; 2021.
© 2022 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2022
You do not currently have access to this content.